News Articles Tagged: Peptide Agonism

The Role of GCGR, GIPR, and GLP-1R Agonism in Obesity Research

NINGBO INNO PHARMCHEM CO.,LTD. examines how targeting GCGR, GIPR, and GLP-1R with peptides like Retatrutide can revolutionize obesity research and treatment.

The Science Behind Retatrutide: A Deep Dive into GCGR, GIPR, and GLP-1R Agonism

NINGBO INNO PHARMCHEM CO., LTD. explains the scientific mechanism of Retatrutide, a potent GCGR, GIPR, and GLP-1R agonist, crucial for obesity and diabetes research.

The Role of GIP and Glucagon Agonism in Advanced Weight Loss Peptides

Explore how GIP and glucagon receptor agonism, exemplified by Retatrutide, enhances weight loss beyond traditional GLP-1 agonists. Learn about the science and potential of these advanced peptide therapies. Provided by NINGBO INNO PHARMCHEM CO.,LTD.

The Science Behind Mazdutide: A Breakthrough in Dual Receptor Agonism

Delve into the scientific principles of Mazdutide, a revolutionary GLP-1 and glucagon receptor dual agonist. Discover its mechanism of action and potential for treating obesity and metabolic disorders, supported by NINGBO INNO PHARMCHEM CO.,LTD.'s research.